The Two-step Conversion of Big Endothelin 1 to Endothelin 1 and Degradation of Endothelin 1 by Subcellular Fractions from Human Polymorphonuclear Leukocytes

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 Aug 1

PMID 1495979

Citations 14

Authors

S Kaw

M Hecker

J R Vane

Affiliations

Soon will be listed here.

Abstract

The metabolism of big endothelin 1 (bET) and endothelin 1 (ET-1) by subcellular fractions from human polymorphonuclear leukocytes (PMNs) was investigated by bioassay and reversed-phase high-performance liquid chromatography. More than 80% of endothelin-converting activity was recovered from the cytosolic fraction, which in addition to ET-1 generated other peptides from bET. The processing of bET to all its metabolites including ET-1 was prevented by the serine protease inhibitor 3,4-dichloroisocoumarin (DCI; 50 microM) or the elastase inhibitor ONO-5046 (100 microM) but not by phenylmethylsulfonyl fluoride (PMSF; 143 microM), another serine protease inhibitor. Paradoxically, human leukocyte elastase, despite generating a bET fragmentation pattern similar to that of PMN cytosol, produced very little ET-1. However, subsequent treatment of the elastase-derived metabolites of bET with PMN cytosol in the presence of ONO-5046 dramatically increased the amount of ET-1 formed. The generation of ET-1 following this intervention was inhibited by DCI. The PMN membrane preparation degraded ET-1 to a major metabolite, similar to that produced from ET-1 by elastase, and several minor products, paralleled by a loss of its smooth muscle contracting activity. The degradation of ET-1 by PMN microsomes was prevented by DCI, PMSF, or ONO-5046. Our results suggest that an elastase-initiated serine protease cascade is responsible for the sequential conversion of bET to ET-1 by the PMN cytosol. Elastase also partly accounts for the ET-metabolizing properties of PMN microsomes.

Citing Articles

Cardiovascular and inflammatory mechanisms in healthy humans exposed to air pollution in the vicinity of a steel mill.

Kumarathasan P, Vincent R, Blais E, Bielecki A, Guenette J, Filiatreault A Part Fibre Toxicol. 2018; 15(1):34.

PMID: 30097052 PMC: 6086065. DOI: 10.1186/s12989-018-0270-4.

Nitrative stress, oxidative stress and plasma endothelin levels after inhalation of particulate matter and ozone.

Kumarathasan P, Blais E, Saravanamuthu A, Bielecki A, Mukherjee B, Bjarnason S Part Fibre Toxicol. 2015; 12:28.

PMID: 26376633 PMC: 4573945. DOI: 10.1186/s12989-015-0103-7.

Correlation between Saliva and Plasma Levels of Endothelin Isoforms ET-1, ET-2, and ET-3.

Gurusankar R, Kumarathasan P, Saravanamuthu A, Thomson E, Vincent R Int J Pept. 2015; 2015:828759.

PMID: 25972900 PMC: 4417981. DOI: 10.1155/2015/828759.

Endothelin-1 and the kidney--beyond BP.

Dhaun N, Webb D, Kluth D Br J Pharmacol. 2012; 167(4):720-31.

PMID: 22670597 PMC: 3575773. DOI: 10.1111/j.1476-5381.2012.02070.x.

Association of endothelin with lung hemorrhage induced by immune complexes in rats.

Teixeira C, Jancar S, Lima W, DOrleans-Juste P, Sirois P Inflammation. 2005; 28(5):253-61.

PMID: 16133998 DOI: 10.1007/s10753-004-6048-x.

References

Sawamura T, Kimura S, Shinmi O, Sugita Y, Kobayashi M, Mitsui Y . Characterization of endothelin converting enzyme activities in soluble fraction of bovine cultured endothelial cells. Biochem Biophys Res Commun. 1990; 169(3):1138-44. DOI: 10.1016/0006-291x(90)92014-q. View

Dickinson K, Tymiak A, Cohen R, Liu E, Webb M, Hedberg A . Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase. Biochem Biophys Res Commun. 1991; 176(1):423-30. DOI: 10.1016/0006-291x(91)90941-y. View

Ohlstein E, Arleth A, Ezekiel M, Horohonich S, Ator M, Caltabiano M . Biosynthesis and modulation of endothelin from bovine pulmonary arterial endothelial cells. Life Sci. 1990; 46(3):181-8. DOI: 10.1016/0024-3205(90)90103-x. View

Yanagisawa M, Masaki T . Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol. 1989; 38(12):1877-83. DOI: 10.1016/0006-2952(89)90484-x. View

McMahon E, Fok K, MOORE W, Smith C, Siegel N, Trapani A . In vitro and in vivo activity of chymotrypsin-activated big endothelin (porcine 1-40). Biochem Biophys Res Commun. 1989; 161(2):406-13. DOI: 10.1016/0006-291x(89)92613-2. View

Greer I, Haddad N, Dawes J, Johnstone F, Calder A . Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989; 96(8):978-82. DOI: 10.1111/j.1471-0528.1989.tb03358.x. View

Peterson G . A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977; 83(2):346-56. DOI: 10.1016/0003-2697(77)90043-4. View

Hecker M, Kaw S, Walsh D . Determination of endothelin-converting enzyme activity by high-performance liquid chromatography-on-line radioactive flow monitoring. J Chromatogr. 1992; 574(2):344-8. DOI: 10.1016/0378-4347(92)80050-z. View

Branch D, Dudley D, Mitchell M . Preliminary evidence for homoeostatic mechanism regulating endothelin production in pre-eclampsia. Lancet. 1991; 337(8747):943-5. DOI: 10.1016/0140-6736(91)91572-c. View

10.

Sessa W, Kaw S, Zembowicz A, ANGGARD E, Hecker M, Vane J . Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases. J Cardiovasc Pharmacol. 1991; 17 Suppl 7:S34-8. DOI: 10.1097/00005344-199100177-00010. View

11.

Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S . Conversion of big endothelin-1 to endothelin-1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochem Biophys Res Commun. 1991; 178(3):899-905. DOI: 10.1016/0006-291x(91)90976-e. View

12.

Modin A, Pernow J, Lundberg J . Phosphoramidon inhibits the vasoconstrictor effects evoked by big endothelin-1 but not the elevation of plasma endothelin-1 in vivo. Life Sci. 1991; 49(22):1619-25. DOI: 10.1016/0024-3205(91)90056-h. View

13.

McMahon E, Palomo M, MOORE W, McDonald J, Stern M . Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc Natl Acad Sci U S A. 1991; 88(3):703-7. PMC: 50881. DOI: 10.1073/pnas.88.3.703. View

14.

Sawamura T, Kasuya Y, Matsushita Y, Suzuki N, Shinmi O, Kishi N . Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem Biophys Res Commun. 1991; 174(2):779-84. DOI: 10.1016/0006-291x(91)91485-u. View

15.

Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamoto T . ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun. 1991; 177(2):814-20. DOI: 10.1016/0006-291x(91)91862-7. View

16.

Vijayaraghavan J, Scicli A, Carretero O, Slaughter C, Moomaw C, Hersh L . The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem. 1990; 265(24):14150-5. View

17.

Okada K, Miyazaki Y, Takada J, Matsuyama K, Yamaki T, Yano M . Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem Biophys Res Commun. 1990; 171(3):1192-8. DOI: 10.1016/0006-291x(90)90811-z. View

18.

Takaoka M, Hukumori Y, Shiragami K, Ikegawa R, Matsumura Y, Morimoto S . Proteolytic processing of porcine big endothelin-1 catalyzed by cathepsin D. Biochem Biophys Res Commun. 1990; 173(3):1218-23. DOI: 10.1016/s0006-291x(05)80916-7. View

19.

Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y . A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988; 332(6163):411-5. DOI: 10.1038/332411a0. View

20.

Travis J . Structure, function, and control of neutrophil proteinases. Am J Med. 1988; 84(6A):37-42. DOI: 10.1016/0002-9343(88)90156-8. View